Koboku An Extract of Magnolia Bark, Inhibits Leukotriene Synthesis in Rat Basophilic Leukemia-1 Cells  by Hamasaki, Yuhei et al.
Allergology International (1997) 46: 187-193
Original Article
Koboku, an extract of magnolia bark, inhibits 
leukotriene synthesis in rat basophilic leukemia-1 cells
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Eriko Muro, Shuichi Yamamoto, Muneaki Matsuo, Tomohiro Ichimaru and 
Sumio Miyazaki 
Department of Pediatrics, Saga Medical School, Saga-City, Japan
ABSTRACT 
To determine anti-allergic effects of Koboku, a Chinese 
herbal medicine, we investigated its inhibitory action 
on the production of cysteinyl leukotrienes (LT) and 
LTB4, which are important chemical mediators in the 
pathogenesis of allergic diseases. A23187-stimulated 
synthesis of cysteinyl LT and LTB4 was measured by 
HPLC in the absence or presence of various concen-
trations of Koboku in rat basophilic leukemia-1 (RBL-1) 
cells. In a dose-dependent manner, Koboku inhibited 
synthesis of cysteiny) LT and LTB4 by up to 92.3 and 
100%, respectively. Immunoglobulin [-mediated 
release of cysteinyl LT and LTB4, which was measured 
by specific radioimmunoassay (RIA) was also inhibited
by Koboku in RBL-2H3 cells. Sites of inhibition of 
Koboku in the metabolic pathway of LT synthesis were 
phospholipase A2 (PLA2) and 5-lipoxygenase (5-LO), 
but not LTC4 synthase or LTA4 hydrolase. We conclude 
that the anti-allergic effect of Koboku may be 
attributable, at least in part, to the inhibition of LT 
synthesis. 
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INTRODUCTION 
Koboku, the bark of Magnolia obovata Thunberg 
(Magnoliaceae), is a component of Chinese herbal folk
medicines1 being used for treating allergic diseases, 
including bronchial asthma. Freeze-dried granules of 
Magnoliae cortex extract, which are produced under 
pharmaceutically controlled methods, are officially 
registered as Koboku in the Pharmacopoeia of Japan. 
The compound is now commercially available. Cysteinyl 
leukotrienes (LTC4, LTD4 and LTE4), arachidonate 5-
lipoxygenase metabolites, are major chemical mediators 
that are released from mast cells by immediate-type 
allergic reactions2 and from eosinophils in allergic 
inflammation.3,4 Cysteinyl leukotrienes (LT) appear to be 
important in producing smooth muscle constriction5'b and
have other properties that affect the inflammatory 
processes, such as the induction of mucus secretion7 or 
the accumulation of inflammatory cells.8 The present 
study examined the possible inhibitory effects of Koboku 
on the in vitro production of cysteinyl LT and LTB4 and 
further clarified its sites of inhibition in the metabolic 
pathway of LT in rat basophilic leukemia-1 (RBL-1) cells, 
which produce a large amount of cysteiny) LT and LTB4.
METHODS 
Materials 
Rat basophilic leukemia-1 cells were obtained from 
Dainippon Pharmaceutical Co. (Tokyo, Japan) and RBL-
2H3 cells were kindly provided by K Maeyama (Depart-
ment of Pharmacology, Tohoku University, Japan). Other 
materials used include anti-biotic-anti-mycotic liquid (a 
mixture of penicillin G, streptomycin and amphotericin 
B), etal bovine serum (FBS) and Dulbecco's modified 
Eagle's medium (DMEM; both from Gibco Oriental, 
Tokyo, Japan), arachidonic acid (AA), LTB4, LTC4, LTD4 
and LTE4 (all from Funakoshi, Tokyo, Japan), LTA4 methyl 
ester (Ultrafine Chemical, Manchester, England), 
A23187, glutathione (reduced form), bovine y-globulin
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and dithiothreitol (Sigma Chemical Co., St Louis, MO, 
USA), adenosine 5'-triphosphate (ATP, monosodium salt; 
from Oriental Yeast Co., Tokyo, Japan), Norit A and
magnolol (Wako, Osaka, Japan) and β-eudesmol
(Nihon Sanso, Tokyo, Japan).5,6,8,9,11,12,14,15-[3H]-
Arachidonic acid, [5,6,8,9,11,12,14,15-3H]-LTB4 
(5.92-8.88TBq/mmo) and [14,15,19,20-3H]-LTC4 
(3.7-8.88TBq/mmol) were obtained from Amersham 
Japan (Tokyo, Japan), purified rat myeloma IgE was 
obtained from Zymed (San Francisco, CA, USA) and 
sheep antiserum to rat IgE was obtained from Bethyl
(Montgomery, TX, USA). Antisera to LTB4 and LTC4 were 
kindly provided by Dr Daniel Tai (University of Kentucky, 
Lexington, KY, USA). Koboku freeze-dried granules were 
obtained from Tsumura Co. (Tokyo, Japan). Other 
materials were reagent grade and were obtained from 
commercial sources. 
Measurement of cysteinyl LT and LTB4 synthesis 
in intact cells
The production of cysteinyl LT (LTC4, LTD4 and LTE4) 
and LTB4 was measured in intact RBL-1 cells by methods 
previously described.9 Cells were grown in DMEM 
supplemented with antibiotic-antimycotic liquid and 10% 
FBS, then distributed into 3.5cm diameter petri dishes
at a density of 2×106 per 2mL. Various concentrations
of Koboku were added to the medium. Cells were 
incubated for 10min prior to exposure to 10-5mol/L
A23187 for 15min at 37℃. The culture medium (2mL)
was then removed and mixed with 3.5mL ice-cold 
methanol. After centrifugation (1000g, 15min), 
the supernatants were applied to a pretreated Sep Pak 
C18 cartridge (Waters Associates, Milford, MA, USA) for 
purification and concentration. A portion (90L) of the 
eluted sample was then injected into a high-performance 
liquid chromatography (HPLC) column for assay of LT. 
 The HPLC system consisted of a computer control 
multi pump and a UV-8010 absorbance detector (TOSO, 
Tokyo, Japan). A Novapak C18 column (Waters
Associates; 0.39×15cm) was used with acetonitrile/
methanol/water/acetic acid (31:17.08:51.24:0.68(v/v)) 
for assay of LT. The solvent was adjusted to pH 4.5 with 
NH4OH. The flow rate was 0.8mL/min and elution was 
monitored at 280nm. Retention times for LTC4, LTD4, 
LTE4, 6-trans-LTB4 diastereoisomers (12-epi-6-trans LTB4 
and 6-trans LTB4) and LTB4 were approximately 6, 8, 9, 
11 and 14min, respectively. Identification of these 
metabolites was based on comigration with authentic
standards and specificity of UV absorbance. Quanti-
fication of LT was based on the peak area ratios with 
respect to authentic standards. 
Measurement of cysteinyl LT and LTB4 synthesis 
in intact RBL-2H3 cells by radioimmunoassay 
Although RBL-1 cells produce a large amount of cysteinyl 
LT and LTB4 after stimulation with A23187, these cells 
have no high-affinity IgE receptors on their surface. 
Therefore, we used RBL-2H3 cells expressing high-affinity 
IgE receptors on their cell surface in this particular study
in which the inhibitory action of Koboku on IgE-mediated 
synthesis of LT was examined. Rat basophilic leukemia-
2H3 cells produce a smaller amount of LTB4 and a much 
smaller amount of cysteinyl LT by IgE-mediated 
stimulation than do RBL-1 cells stimulated with A23187. 
We therefore used a specific radioimmunoassay (RIA) for 
the measurement of cysteinyl LT and LTB4 in this study.10 
 Rat basophilic leukemia-2H3 cells were distributed 
into 24-well plates at a density of 106 cells/mL. Rat IqE
(0.1μL) was added to each well and the cells were
incubated for 6h at 37℃. The medium was then
discarded and, after the addition of fresh DMEM (300
μL), cells were exposed to various concentrations of
Koboku and were incubated for 10min prior to
stimulation with anti-IgE (0.1μL) for 30min at 37℃. The
medium was recovered and stored at -70℃ until
easurements of cysteinyl LT and LTB4 were performed. 
Radioimmunoassay for cysteinyl LT and LTB4 was
performed as previously described.10 Brietly, 100μL of
each sample was incubated at 4℃ for 10h with 100μL
each of anti-LTC4 antiserum, [3H]-LTC4 and 50mmol/L 
sodium phosphate buffer (pH 7.4) containing 0.9% NaCl
and γ-globulin (1mg/mL). Free [3H]-LTC4 was seporoted
by centrifugation at 1000g for 10min after the addition
of 0.5 mL γ-globulin-cooted chorcool (Norit A) to the
assay mixture. The resulting supernatant was transferred 
to a scintillation vial containing 5mL scintillation fluid 
and the radioactivity was measured with a liquid
scintillation counter (model LS7500; Beckman, Irvine, 
CA, USA). The amount of LTC4 was calculated from a 
standard curve. The final dilution of anti-LTB4 antiserum 
was 1:2000. The minimal detectable amount of LTC4 was 
8 pg per assay tube. The percentages of cross-reactivity 
of the anti-LTC4 anti-serum with LTB4, LTD4 and LTE4 and 
were 0.1, 139 and 3.2%, respectively. Therefore, the 
production of LTC4 measured by RIA in the present study 
represents the sum of LTC4 and LTD4 levels, which are
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expressed as cysteinyl LT. For the RIA of LTB4, the same 
procedures were followed with the use of anti-LTB4 anti-
serum (final dilution 1:2000) and [3H]-LTB4 instead of 
anti-LTC4 antiserum and [3H]-LTC4, respectively. The 
minimal detectable amount of LTB4 was 32 pg per assay 
tube. The percentages of cross-reactivity of anti-LTB4 anti-
serum with LTC4, LTD4 and LTE4 were <0.1%; those with 
20OH-LTB4 and 20COOH-LTB4 were <5%. 
Assay of PLA2 activity in intact cells 
Cells were seeded into a 24-well plate at a density of
5×105/mL and were incubated for 16h at 37℃ with
[3H]-AA (1.11 kBq; 0.15pmol). The supernatant was 
discarded and was replaced with 1mL fresh DMEM
without FBS. Cells were incubated for 30min at 37℃
and were then exposed to Koboku for 10min and to 
10-5mol/LA23187 for 5min. Radioactivity released into 
the medium was counted with a type 2250CA liquid 
scintillation counter (Packard, Meriden, CT, USA). The
inhibitory actions of magnolol or (3-eudesmol on PLA2,
both of which are components in Koboku, were also 
examined by the same assay procedures. 
Assay of 5-lipoxygenase activity
The production of cysteinyl LT and LTB4 was measured 
with cell lysate as the enzyme source and free AA as the 
substrate. Cells were washed and were suspended at a 
density of 108/mL in a solution containing (in mmol/L): 
NaCl 137; KCl 2.6; sodium phosphate 0.36; HEPES 10 
(pH 7.5); EDTA 1; dithiothreitol 1. The cell suspension 
was sonicated (Branson (Plainview, NY, USA) Model 
W200-P, level 4) on ice three times for 15 s each time.
Two microliters of 0.1mol/L AA were added to 198μL
reaction buffer containing cell ysate (50μL), 3mmol/L
glutathione, 0.1mmol/L ATP and 2mmol/L CaCl2, and
the reaction mixture was incubated at 37℃ for 5min
either in the absence or in the presence of Koboku. The 
reaction was stopped by adding 2mL ice-cold methanol. 
After centrifugation, the supernatant was applied to a 
pretreated Sep Pak Cl8 cartridge. Leukotrienes were 
separated and measured as described for intact cell 
experiments. 
Assay of LTC4 synthase and LTA4 hydrolase 
To evaluate the action of Koboku on the activity of LTC4 
synthase and LTA4 hydrolase without the influence of 
5-L0, the production of cysteinyl LT and LTB4 was
measured in intact RBL-l cells after the addition of LTA4-
free acid as a substrate into the incubation medium. 
Twenty microgram LTA4-free acid, prepared as previously 
described,11 were added to the medium and the mixture
was incubated at 37℃ for 5min in the absence or
presence of Koboku. Produced cysteinyl LT and LTB4 were 
assayed by HPLC as described earlier. 
Statistical analysis
Data are presented as the mean±SEM. Statistical
analysis was performed by one-way analysis of variance. 
The significance of the differences between groups 
was evaluated by Sheffe's multiple comparison method. 
A level of P<0.05 was accepted as statistically 
significant. 
RESULTS
Measurement of cysteinyl LT and LTB4 synthesis 
in intact cells 
Calcium ionophore-stimulated cells produced LTC4, 
LTD4, LTE4 and LTB4 (Fig. 1a). The production of LTC4, 
LTD4 and LTE4 contributed to total cysteinyl LT production. 
A dose-response curve of the effects of A23187 on 
LT-production is shown in Fig. 1 b. As the production of 
cysteinyl LT and LTB4 were increased in a dose-dependent 
manner by A23187, we used a concentration of 
10-5mol/L A23187 throughout the studies. As shown 
in Fig. 2a,b, the production of cysteinyl LT and LTB4 
was dose-dependently and significantly inhibited by 
Koboku.
Effect of Koboku on the IgE-mediated release 
of cysteinyl LT and LTB4 
The IgE-loaded RBL-2H3 cells synthesized cysteinyl LT 
and LTB4 following stimulation with anti-IgE. The 
production of cysteinyl LT was completely inhibited by
Koboku at 100μg/mL (Fig.3a). The production of LTB4
was dose-dependently and significantly inhibited by 
Koboku, as shown in Fig. 3b.
Effects of Koboku on PLA2 activity 
The average incorporation of [3H]-AA into RBL-1 cells 
was approximately 75% after 16h (data not shown). At
100μg/mL, Koboku significantly inhibited the release
of [3H]-AA from A23187-stimulated RBL-1 cells by 57%
190 Y HAMASAKI ET AL.
Fig. 1 Reverse-phase (RP) HPLC profiles. (a) Representative
RP-HPLC profiles of Iipoxygenase metabolites from 2×106 cells
stimulated with calcium ionophore A23187 (10-5mol/L) for
15min at 37℃. 1, leukotriene(LT) C4; 2, LTD4; 3, LTE4;
4, 6-trans-LTB4 diastereoisomers; 5, LTB4. (b) Dose-response 
curve of LT production stimulated with A23187 from 10-6 to
10-5mol/L.(-), production of cysteinyl LT; (-), production
of LTB4.
(Fig. 4). β-Eudesmol showed no inhibition of PLA2 activity
at 10-5mol/L. Magnolol significantly inhibited release by 
28.4% at a concentration of 10-5mol/L (Table 1).
Effects of Koboku on 5-LO 
To examine the actions of Koboku on 5-LO, we incubated 
cell lysates with AA as the substrate for 10min in the 
absence or presence of Koboku. The production of 
cysteinyl LT and LTB4 was inhibited by Koboku (100
μg/mL) by 52 and 40%, respectively (Fig.5).
Fig. 2 Effect of Koboku on A23187-stimulated synthesis of 
(a) cysteinyl leukotrienes (LT) and (b) LTB4 in RBL-1 cells. Cells
were stimulated with 10μmol/L A23187 for 15min in the
absence (□) or presence (■) of various concentrations of
Koboku. The production of LT was measured by HPLC. Data
are the mean±SEM (n=3). *P<0.05, **P<0.01 versus
control.
Effects of Koboku on LTA4 hydrolase and LTC4 
synthase
Koboku (100μg/mL), which significantly inhibited
A23187-stimulated production of LT in previous studies, 
showed no significant inhibition of the synthesis of 
cysteinyl LT and LTB4 when cells were incubated with LTA4-
free acid as the common substrate of LTA4 hydrolase and 
LTC4 synthase (data not shown).
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Fig. 3 The action of Koboku on the IgE-mediated production 
of (a) cysteinyl leukotrienes (LT) and (b) (LTB4). The IgE-loaded 
2H3 cells were stimulated with anti-IgE for 30min in the
presence of various concentrations of Koboku (■). The
production of cysteinyl LT and LTB4 was then measured by using
specific RIA, as described in Methods. Data are the mean±SEM
(n=4). *P<0.05, **P<0.01 versus control (no Koboku
treatment group; □).
Table 1. Inhibitory action of magnolol or β-eudesmol on the
release of [3H]-arachidonic acid from A23187-stimulated cells
Data are the mean±SEM (n=4; *P=0.0018).
Fig. 4 Action of Koboku on phospholipase A2 activity. [3H]-
Arachidonic acid was incorporated into cell membranes and
was stimulated with A23187 in the absence (□) or presence (■)
of Koboku. Released radioactivity in the medium was counted.
Data are the mean±SEM (n=4). **P<0.01 versus control.
DISCUSSION 
Our results show that Koboku inhibits the A23187-
stimulated production of cysteinyl LT (LTC4, LTD4, LTE4) 
and LTB4 in intact RBL-1 cells. Koboku also inhibited the 
IgE-mediated release of cysteinyl LT and LTB4 in RBL-2H3 
cells, which have high-affinity IgE-receptors on their cell 
surface. 
 Following the increase in the intracellular calcium 
concentration ([Ca2+]) induced by A23187 and IgE
receptor-mediated stimulation, AA is released from 
membrane phospholipids by PLA2, the first step enzyme. 
There are at least three different types of PLA2.12 Of these, 
a high molecular weight cytosolic PLA2 (cPLA2) is mainly 
responsible for AA metabolism.13 Cytosolic PLA2 trans-
locates to the perinuclear membrane, the site of LT 
synthesis.14 Phospholipase A2 activity, as reflected by the 
release of [3H]-AA, was significantly and dose-
dependently inhibited by Koboku. The second step 
enzyme, 5-LO, is also translocated from the cytosol to the 
perinuclear membrane following an increase in [Ca2+]15 
Koboku inhibited the production of cysteinyl LT and LTB4 
when AA was used as the substrate in the cell-free study, 
but it did not inhibit the production of cysteinyl LT and 
LTB4 when LTA4-free acid was used as the substrate. These 
results indicate that Koboku inhibits 5-LO as well as 
PLA2. The possible sites of inhibition by Koboku in the 
arachidonate-LT synthetic pathway are illustrated in 
Fig. 6.
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Fig. 5 Inhibitory action of Koboku on 
the production of leukotrienes (LT) in 
a cell-free assay. Cell lysate (as an 
enzyme source) was incubated with 
free arachidonic acid (10-1mol/L) as 
the substrate in the absence (control) or
presence of Koboku. (■), cysteinyl LT;
(D), LTB4. Data are the mean±SEM
(n=3). *P<0.05 versus control.
Fig. 6 Arachidonate 5-lipoxygenase 
(5-LO) metabolic pathway; arrows 
indicate the possible inhibitory sites of 
action of Koboku. PHS, prostaglandin 
H2 synthase; PGH2, prostaglandin H2; 
LTC4, LTB4, LTA4, leukotriene C4, B4 and 
A4, respectively; PLA2, phospholipase 
A2; FLAP, five lipoxygenase activating 
protein; 5-H PETE, 5-hydroxyperoxy-
eicosotetranoic acid.
 There have been no pharmacokinetic studies done 
with Koboku in humans. A standard dose of Chinese 
herbal medicine for patients is 7.5g/day (divided into 
three doses). If 2.5g Koboku is given and 100% of the 
compound is absorbed and is equally distributed 
throughout the aqueous compartments of the body of a 
50kg adult, the calculated concentration of Koboku in
the body fluids would be approximately 80μg/mL,
Magnolol is a major component of Koboku and is 
approximately 5% (w/w) of Koboku. When the 
concentration of magnolol is estimated by the simulated 
calculation of Koboku in the body fluid, the concentration
of magnolol is found to be approximately 4μg/mL
(=1.5×10-5mol/L). Thus, the serum concentrations of
Chinese herbal medicines and their components possibly 
reach the concentrations that were examined in the
present study, although this is a simple simulation and 
there is no definitive evidence as to the actual 
concentrations reached in the human body. 
 Koboku contains bioactive chemicals such as
β-eudesmol, α-pinene, β-pinene, camphene, limonene,
magn curarine, magnoflorine, magnolianin, magnolol 
and honokiol. Honokiol, a Biphenyl compound, 
reportedly inhibits 5-LO activity but not PLA2 activity.16 This 
suggests that the inhibitory action of Koboku on LT 
synthesis is, in part, attributable to honokiol. We
examined the inhibitory action of β-eudesmol and
m gnolol, which are commercially available components 
of Koboku, on PLA2 activity. Magnolol at a concentration 
of 10-5mol/L, but not 13-eudesmol, inhibited PLA2 activity 
by 28%, suggesting that magnolol is responsible for the 
inhibition of PLA2 by Koboku. Other unidentified
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substances may also be responsible for inhibitory action. 
PLA2 inhibition contributes to the overall inhibition of LT 
synthesis. Koboku inhibition of 5-LO activity, as measured 
by cysteinyl LT and LTB4 production using AA as the 
substrate, was 52 and 42%, respectively. Inhibition of 
PLA2 activity at the same Koboku concentration was 57%. 
Thus, Koboku demonstrated a synergistic inhibition of LT 
synthesis through its inhibition of two pivotal enzymes, 
PLA2 and 5-LO. However, the detailed mechanism of this
inhibition remains to be elucidated. Although we have 
demonstrated that Koboku and its components inhibit the 
synthesis of LT, which play important roles in the 
development of allergic diseases, there may be 
fundamental differences between in vitro studies and in 
vivo clinical effectiveness. In order to lessen the gap, 
further pharmacokinetic studies on Koboku in humans 
are needed.
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